Use of the architect-i2000 estradiol immunoassay during in vitro fertilization

Clinical Chemistry

Volumn 49, Issue 1, 2003, Pages 183-186

  Taieb, Joëlle ^a,b   Benattar, Clarisse ^a,b   Diop, Rokhaya ^a,b   Birr, Anne Sophie ^a,b   Lindenbaum, Albert ^a,b  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b Dept of Biochem and Hormonology ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; ESTRADIOL VALERATE; GONADORELIN; GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ARTICLE; CALIBRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FUNCTION TEST; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LUMINESCENCE; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVARY HYPERSTIMULATION; OVULATION INDUCTION; SENSITIVITY AND SPECIFICITY; TRANSVAGINAL ECHOGRAPHY;

AUTOANALYSIS; CHEMILUMINESCENT MEASUREMENTS; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; HUMANS; IMMUNOASSAY; PARTICLE SIZE;

EID: 0037230518     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.1.183     Document Type: Article

References (28)

1. Howles CM, Macnamee MC. Endocrine monitoring for assisted human conception. Br Med Bull 1990;46:616-27.
2. Balos O, Lundkvist O, Wide L, Bergh T. Ultrasonographical and hormonal description of the normal ovulatory menstrual cycle. Acta Obstet Gynecol Scand 1994;73:790-6.
3. Muse MD, Wilson EA. Monitoring ovulation: Use of biochemical and biophysical parameters. Semin Reprod Endocrinol 1986;4:301-9.
4. Fossum G, Vermesh M, Kletzky OA. Biochemical and biophysical indices of follicular development in spontaneous and stimulated ovulatory cycles. Obstet Gynecol 1990;75:407-11.
5. Sushanek E, Huderer K, Dobec D, Hlavati V, Simunic V, Grizelj V. Number of follicles, oocytes and embryos in human in vitro fertilization is relative to serum estradiol and progesterone patterns during different types of ovarian hyperstimulation. Eur J Obstet Gynecol Reprod Biol 1994;56:121-7.
6. Dor J, Seidman DS, Ben-Shlomo I, Levran D, Karasik A, Mashiach S. The prognostic importance of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro fertilization (IVF) treatment. J Assist Reprod Genet 1992;9:228-32.
7. Levran D, Lopata A, Nayudu PL, Martin MJ, McBain JC, Bayly CM, et al. Analysis of the outcome of in-vitro fertilization in relation to the timing of human chorionic gonadotropin administration by the duration of estradiol rise in stimulated cycles. Fertil Steril 1985;44:335-41.
8. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992;58:249-61.
9. Morris RS, Paulson RJ, Sauer MV, Lobo RA. Predictive value of serum estradiol concentrations and oocyte number in severe ovarian hyperstimulation syndrome. Hum Reprod 1995;10:811-4.
10. Hughes EG, Fedorkow DM, Daya S, Sagle MA, Van de Kopper P, Collins JA. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intra-Fallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 1992;58:888-96.
11. Licciardi FL, Liu HC, Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 1995;64:991-4.
12. Spencer CA, Takeuchi M, Kararosyan M. Current status and performance goals for serum thyrotropin (TSH) assays. Clin Chem 1997;42:140-5.
13. Taieb J, Benattar C, Birr AS, Lindenbaum A. Limitations of steroid determination by direct immunoassay. Clin Chem 2002;48:583-5.
14. Taieb J, Sarnel C, Benattar C, Lindenbaum A. A new technique for measuring 17β-estradiol using Kryptor (Cis Bio International): utilization to monitor ovulation stimulation. Ann Biol Clin 2000;58:71-9.
15. Taieb J, Benattar C, Chalas J, Messaoudi C, Lindenbaum A. Comparaison de cinq techniques de dosage direct du 17β estradior. Immunoanal Biol Spec 1997;12:267-74.
16. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
17. Schroder V, Thode J. Six direct radioimmunoassays of estradiol evaluated. Clin Chem 1988;34:949-52.
18. Lee CS, Smith NM, Kahn SN. Analytical variability and clinical significance of different assays for serum estradiol. J Reprod Med 1991;36:156-60.
19. Mikkelsen AL, Borggaard B, Lebech PE. Results of serial measurement of estradiol in serum with six different methods during ovarian stimulation. Gynecol Obstet Invest 1996;41:34-40.
20. Tummon I, Stemp J, Rose C, Vandenberghe H, Bany B, Tekpetey F, et al. Precision and method bias of two assays for oestradiol: consequences for decisions in assisted reproduction. Hum Reprod 1999;14:1175-7.
21. Büttner J, Philosophy of measurement by means of immunoassays. Scand J Clin Lab Invest 1991;51(Suppl 205):11-20.
22. Potischman N, Falk RT, Laiming VA, Siiteri PK, Hoover RN. Reproducibility of laboratory assays for steroid hormone and sex hormone-binding globulin. Cancer Res 1994;54:5363-7.
23. Franek M. Structural aspects of steroid-antibody specificity. J Steroid Biochem 1987;28:95-108.
24. Grover PK, Odell WD, Specificity of antisera to sex steroids I. The effect of substitution and stereochemistry. J Steroid Biochem 1977;8:121-6.
25. Cook NC, Read GF. Oestradiol measurement in women on oral replacement therapy: the validity of commercial test kits. Br J Biomed Sci 1995;52:97-101.
26. Yuzpe AA, Nisker JA, KapLan BR, Tummon IS, AuckLand J. Nafarelin acetate for down regulation in in vitro fertilization. J Reprod Med 1995;40:83-8.
27. Cohen J. A coefficient of agreement for nominal scales. Educ Psych Meas 1960;20:37-46.
28. Diver MJ, Nisbet JA. Warning on plasma oestradiol measurement. Lancet 1987;15:17-35.